Try the Demo today!
| SEC Filing | Insider | Company | Trade Date | Transaction | Shares | Avg. Price | Total | % Holdings | Return |
|---|---|---|---|---|---|---|---|---|---|
| 08-Sep-23 5:47 PM View:  | Abrams Michael S Chief Financial Officer | Arch Therapeutics, Inc. (ARTH) | 31-Aug-23 | Private Purchase | 10,292 | $0.28 | $2,830.30 | 100% 0 to 10.29K | |
| 08-Sep-23 5:47 PM View: | Hicks Laurence Director | Arch Therapeutics, Inc. (ARTH) | 31-Aug-23 | Private Purchase Duplicate | 10,292 | $0.28 | $2,830.30 | 100% 0 to 10.29K | |
| 08-Sep-23 5:47 PM View: | Norchi Terrence W PRESIDENT AND CHIEF EXECUTIVE Director | Arch Therapeutics, Inc. (ARTH) | 31-Aug-23 | Private Purchase | 6,862 | $0.28 | $1,887.05 | 100% 0 to 6.86K | |
| 08-Jul-22 4:57 PM View: | Abrams Michael S Chief Financial Officer | Arch Therapeutics, Inc. (ARTH) | 06-Jul-22 | Grant | 108,652 | -- | -- | 100% 0 to 108.65K | |
| 08-Jul-22 4:53 PM View: | Hicks Laurence Director | Arch Therapeutics, Inc. (ARTH) | 06-Jul-22 | Grant Duplicate | 108,652 | -- | -- | 100% 0 to 108.65K | |
| 08-Jul-22 4:55 PM View: | Norchi Terrence W PRESIDENT AND CHIEF EXECUTIVE | Arch Therapeutics, Inc. (ARTH) | 06-Jul-22 | Grant | 72,435 | -- | -- | < 1% 12.91M to 12.98M | |
| 23-Jun-20 7:59 AM View: | Sulat James R Director | Arch Therapeutics, Inc. (ARTH) | 22-Jun-20 | Exercise (out-of-the-money) | 454,546 | $81,818.30 | $37,190,201,344.00 | 35% 1.29M to 1.75M | |
| 20-Jul-18 12:04 PM View: | Norchi Terrence W President & CEO Director 10% Owner | Arch Therapeutics, Inc. (ARTH) | 19-Jul-18 | Grant | 360,000 | -- | -- | 11% 3.2M to 3.56M | |
| 20-Jul-18 12:00 PM View: | Dhillon Avtar S Director | Arch Therapeutics, Inc. (ARTH) | 19-Jul-18 | Grant | 220,000 | -- | -- | 3% 8.3M to 8.52M | |
| 20-Jul-18 12:05 PM View: | Sulat James R Director | Arch Therapeutics, Inc. (ARTH) | 19-Jul-18 | Grant | 110,000 | -- | -- | 42% 260.0K to 370.0K | |
| 20-Jul-18 12:04 PM View: | Davis Richard E CFO & TREASURER | Arch Therapeutics, Inc. (ARTH) | 19-Jul-18 | Grant | 275,000 | -- | -- | 46% 603.0K to 878.0K | |
| 18-Jul-18 2:33 PM View: | Sulat James R Director | Arch Therapeutics, Inc. (ARTH) | 16-Jul-18 | Option Exercise | 30,000 | $0.37 | $11,100.00 | 13% 230.0K to 260.0K | |
| 06-Feb-17 11:28 AM View: | Dhillon Avtar S Director | Arch Therapeutics, Inc. (ARTH) | 03-Feb-17 | Grant | 400,000 | -- | -- | 5% 7.9M to 8.3M | |
| 06-Feb-17 11:29 AM View: | Norchi Terrence W President & CEO Director 10% Owner | Arch Therapeutics, Inc. (ARTH) | 03-Feb-17 | Grant | 650,000 | -- | -- | 25% 2.55M to 3.2M | |
| 06-Feb-17 11:26 AM View: | Davis Richard E CFO & TREASURER | Arch Therapeutics, Inc. (ARTH) | 03-Feb-17 | Grant | 500,000 | -- | -- | 485% 103.0K to 603.0K | |
| 06-Feb-17 11:30 AM View: | Sulat James R Director | Arch Therapeutics, Inc. (ARTH) | 03-Feb-17 | Grant | 200,000 | -- | -- | 667% 30.0K to 230.0K | |
| 31-May-16 1:15 PM View: | Sulat James R Director | Arch Therapeutics, Inc. (ARTH) | 26-May-16 | Purchase | 111,111 | -- | -- | 15% 757.82K to 868.93K | |
| 05-May-16 12:41 PM View: | Dhillon Avtar S Director | Arch Therapeutics, Inc. (ARTH) | 03-May-16 | Grant | 737,000 | -- | -- | 10% 7.16M to 7.9M | |
| 05-May-16 12:45 PM View: | Norchi Terrence W President & CEO Director 10% Owner | Arch Therapeutics, Inc. (ARTH) | 03-May-16 | Grant | 1,130,000 | -- | -- | 80% 1.42M to 2.55M | |
| 05-May-16 12:42 PM View: | Sulat James R Director | Arch Therapeutics, Inc. (ARTH) | 03-May-16 | Grant | 30,000 | -- | -- | 100% 0 to 30.0K | |
| 05-May-16 12:43 PM View: | Davis Richard E CFO & TREASURER | Arch Therapeutics, Inc. (ARTH) | 03-May-16 | Grant | 103,000 | -- | -- | 100% 0 to 103.0K | |
| 26-Jun-13 5:18 PM View: | Norchi Terrence W Pres, CEO, Sec, and Treas Director 10% Owner | Arch Therapeutics, Inc. (ARTH) | 26-Jun-13 | Acquisition (other) | 1,419,080 | -- | -- | 14% 10.0M to 11.42M | |
| 26-Jun-13 5:16 PM View: | Dhillon Avtar S Director 10% Owner | Arch Therapeutics, Inc. (ARTH) | 25-Jun-13 | Acquisition (other) | 160,373 | -- | -- | 2% 7.0M to 7.16M |
